Tandem Diabetes Care

TNDM61

$30.81arrow_drop_up0.16%$0.05

TNDM61

$30.81

arrow_drop_up0.16%$0.05

Performance History

Key Stats
Open	$30.75
Prev. Close	$30.74
EPS	-1.94
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	30.00	31.69
52 Week Range	13.82	53.69

Ratios







EPS	-1.94

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Tandem Diabetes Care (TNDM)

Tandem Diabetes Care Inc (TNDM) is a leading medical device company focused on the development and commercialization of innovative therapies and technologies for people with diabetes. The company's flagship product is the t:slim X2 Insulin Pump, which features a touchscreen interface and advanced sensor technology. Tandem Diabetes Care is committed to helping individuals with diabetes improve their quality of life through the use of its products.

Tandem Diabetes Care Inc's stock price history has shown significant growth over the past few years. In 2018, the stock price experienced a sharp increase, reaching an all-time high of $78.50 per share. Since then, the stock price has fluctuated but has generally remained at a higher level. As of [current date], the stock price is [current price] per share.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. John F. Sheridan
Headquarters: San Diego
Employees: 2600
Exchange: NASDAQ

Keep an eye on Tandem Diabetes Care

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Tandem Diabetes Care 's (TNDM) price per share?

The current price per share for Tandem Diabetes Care (TNDM) is $30.81. The stock has seen a price change of $0.05 recently, indicating a 0.16% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Tandem Diabetes Care (TNDM)?

For Tandem Diabetes Care (TNDM), the 52-week high is $53.69, which is 74.26% from the current price. The 52-week low is $13.82, the current price is 122.94% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Tandem Diabetes Care (TNDM) a growth stock?

Tandem Diabetes Care (TNDM) has shown an average price growth of -3.66% over the past three years. It has received a score of 22 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Tandem Diabetes Care as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Tandem Diabetes Care (TNDM) stock price performance year to date (YTD)?

As of the latest data, Tandem Diabetes Care (TNDM) has a year-to-date price change of 8.75%. Over the past month, the stock has experienced a price change of -2.99%. Over the last three months, the change has been -30.45%. Over the past six months, the figure is -40.44%. Looking at a longer horizon, the five-year price change stands at -56.72%.

help

Is Tandem Diabetes Care (TNDM) a profitable company?

Tandem Diabetes Care (TNDM) has a net income of -$222.61M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 49.17% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -10.7% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $747.72M, although specific revenue growth data is currently not available. The gross profit is $367.69M. Operating income is noted at -$233.23M. Furthermore, the EBITDA is -$130.7M.

help

What is the market capitalization of Tandem Diabetes Care (TNDM)?

Tandem Diabetes Care (TNDM) has a market capitalization of $2.02B. The average daily trading volume is 30.68, indicating the stock's liquidity and investor engagement.